Clinical Trial Update: Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating postoperative radiation, cisplatin, and panitumumab in locally advanced head and neck cancer completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Neoplasms

Drugs mentioned

• CISPLATIN (cisplatin)
• Panitumumab (panitumumab)
• Radiation therapy

Snippet

Sponsor: Robert Ferris | Conditions: Cancer of Head, Cancer of Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2016-08-09